Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Cognition Therapeutics, Inc. (CGTX) had Free Cash Flow per Share of $-0.54 for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
-- |
|
$-25.79M |
|
-- |
|
-- |
|
$50.72M |
|
$-50.72M |
|
$24.94M |
|
$-25.79M |
|
$-25.79M |
|
$-25.79M |
|
$-25.79M |
|
$-25.79M |
|
$-25.79M |
|
$-50.72M |
|
$-50.47M |
|
30.03M |
|
30.03M |
|
$-0.86 |
|
$-0.86 |
|
Balance Sheet Financials | |
$34.22M |
|
$0.28M |
|
$0.94M |
|
$35.16M |
|
$10.17M |
|
-- |
|
$0.52M |
|
$10.69M |
|
$24.47M |
|
$24.47M |
|
$24.47M |
|
32.16M |
|
Cash Flow Statement Financials | |
$-16.02M |
|
$-0.15M |
|
$4.52M |
|
$41.56M |
|
$29.92M |
|
$-11.64M |
|
$4.35M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
3.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.16M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-105.37% |
|
-105.37% |
|
-73.34% |
|
-105.37% |
|
$0.76 |
|
Free Cash Flow per Share |
$-0.54 |
$-0.53 |